Target's General Information
Target ID T84631
Target Name Coagulation factor Xa (F10)
Synonyms Fxa; Factor Xa; F10; Activated coagulation factor X
Target Type Successful
Gene Name F10
Biochemical Class Peptidase
UniProt ID FA10_HUMAN
Target's Expression Profile in Disease Related Tissue between Patients and Normal People
Disease Renal cancer
Example drug Human coagulation factor X BLA submitted [1], [2], [3]
Tissue Kidney
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.28
Z-score: -0.9
P-value: 4.84E-02
Level of differential expression between the patients in the disease section of the tissue section of the tissue adjacent to the disease section Fold-change: -0.26
Z-score: -0.99
P-value: 2.78E-05
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles of the patients in the normal section of the tissue adjacent to the disease section
Target gene expression profiles in the tissue of healthy individual
Target's Expression Profile across Various Tissues of Healthy Individual
References
REF 1 FDA Accepts BPL's Amended BLA Submission for Coagadex (Coagulation Factor X, Human). BPL Bio Products Laboratory USA, Inc.
REF 2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
REF 3 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.